Neos Therapeutics, Inc. (38)
Browse by Contract Category
Contracts
-
Consent, Waiver and Amendment No. 1 to Loan and Security Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics,...
(Filed With SEC on March 22, 2021)
-
Commitment Letter, dated as of December 10, 2020, by and between Aytu BioScience, Inc. and Neos Therapeutics, Inc
(Filed With SEC on December 11, 2020)
-
Agreement and Plan of Merger, dated as of December 10, by and among Neos, Therapeutics, Inc., Aytu BioScience, Inc. and Neutron Acquisition Sub, Inc
(Filed With SEC on December 11, 2020)
-
Form of Parent Stockholder Voting Agreement
(Filed With SEC on December 11, 2020)
-
Second Amendment to Employment Agreement, by and between the Registrant and John M. Limongelli, dated as of April 1, 2020
(Filed With SEC on August 10, 2020)
-
Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos...
(Filed With SEC on March 22, 2021)
-
Subordination Agreement, by and among Neos, Aytu, Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos Therapeutics Commercial, LLC, Pharmafab Texas, LLC and Encina Business...
(Filed With SEC on February 8, 2021)
-
Subordination Agreement, by and among Neos, Aytu, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P
(Filed With SEC on February 8, 2021)
-
Registration Rights Agreement, by and between Neos and Aytu
(Filed With SEC on February 8, 2021)
-
Unsecured Convertible Promissory Note, by and between Neos and Aytu
(Filed With SEC on February 8, 2021)
-
Form of Company Stockholder Voting Agreement
(Filed With SEC on December 11, 2020)
-
Limited Waiver, dated as of December 10, 2020, by and between Neos and the Deerfield Lenders
(Filed With SEC on December 11, 2020)
-
Form of Unsecured Convertible Promissory Note, by and between Neos and Aytu
(Filed With SEC on December 11, 2020)
-
Deerfield Consent Letter, dated as of December 10, 2020, by and among Aytu, Neos and the Deerfield Lenders
(Filed With SEC on December 11, 2020)
-
Commitment Letter, dated as of December 10, 2020, by and between Encina, Encina Business Credit SPV, LLC, Neos and Aytu
(Filed With SEC on December 11, 2020)
-
Limited Waiver to Loan and Security Agreement, dated as of December 10, 2020, by and between Neos, Encina and Encina Business Credit SPV, LLC
(Filed With SEC on December 11, 2020)
-
Limited Waiver, dated as of November 9, 2020, among the Registrant, its subsidiary guarantors, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P., as lenders,...
(Filed With SEC on November 9, 2020)
-
Third Amendment to Employment Agreement, by and between the Registrant and John M. Limongelli, dated as of June 18, 2020
(Filed With SEC on August 10, 2020)
-
Third Amendment to Amended and Restated Employment Agreement, by and between the Registrant and Richard I. Eisenstadt, dated as of June 18, 2020
(Filed With SEC on August 10, 2020)
-
Third Amendment to Employment Agreement, by and between the Registrant and Gerald McLaughlin, dated as of June 18, 2020
(Filed With SEC on August 10, 2020)
-
Second Amendment to Employment Agreement, by and between the Registrant and Gerald McLaughlin, dated as of April 1, 2020
(Filed With SEC on August 10, 2020)
-
Second Amendment to Amended and Restated Employment Agreement, by and between the Registrant and Richard I. Eisenstadt, dated as of April 1, 2020
(Filed With SEC on August 10, 2020)
-
Neos Therapeutics, Inc. Non-Employee Director Compensation Policy dated June 10, 2020
(Filed With SEC on June 11, 2020)
-
U.S. Small Business Administration Paycheck Protection Program Note dated April 18, 2020 by and between the Registrant and First Republic Bank
(Filed With SEC on May 11, 2020)
-
Employment Agreement dated March 18, 2019, by and between the Registrant and John Limongelli (corrected version of previously-filed exhibit)
(Filed With SEC on May 11, 2020)
-
Fifth Amendment to Facility Agreement, dated as of May 6, 2020, by and among Neos Therapeutics, Inc., the guarantor parties thereto, Deerfield Private Design Fund III, L.P. and...
(Filed With SEC on May 7, 2020)
-
Form of Second Amended and Restated Senior Secured Convertible Note
(Filed With SEC on May 7, 2020)
-
First Amendment to Amended and Restated Employment Agreement, by and between the Registrant and John Limongelli, dated as of October 1, 2019
(Filed With SEC on March 13, 2020)
-
First Amendment to Amended and Restated Employment Agreement, by and between the Registrant and Richard Eisenstadt, dated as of October 1, 2019
(Filed With SEC on March 13, 2020)
-
First Amendment to Employment Agreement, by and between the Registrant and Gerald McLaughlin, dated as of October 1, 2019
(Filed With SEC on March 13, 2020)
-
Description of Capital Stock
(Filed With SEC on March 13, 2020)
-
Fourth Amendment to the Facility Agreement, dated as of October 2, 2019, by and between Deerfield Private Design Fund III, L.P., Deerfield Special Situations Fund, L.P. and...
(Filed With SEC on October 3, 2019)
-
Loan and Security Agreement, dated as of October 2, 2019, by and between Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC and Neos Therapeutics, LP, as borrowers, Neos...
(Filed With SEC on October 3, 2019)
-
Intercreditor Agreement, dated as of October 2, 2019, by and between the Agent, Deerfield Mgmt, L.P., and certain creditors, including Deerfield Private Design Fund III, L.P. and...
(Filed With SEC on October 3, 2019)
-
Neos Therapeutics, Inc. Non-Employee Director Compensation Policy dated June 13, 2019
(Filed With SEC on June 18, 2019)
-
Third Amendment to Facility Agreement dated as of March 26, 2019 by and among the Registrant, Deerfield Private Design Fund III, L.P., and Deerfield Special Situations Fund, L.P
(Filed With SEC on May 10, 2019)
-
Employment Agreement dated March 18, 2019, by and between the Registrant and John Limongelli
(Filed With SEC on May 10, 2019)
-
Settlement Agreement, by and between the Registrant and Teva Pharmaceuticals USA, Inc., dated as of December 21, 2018
(Filed With SEC on March 18, 2019)